OTX-TKI 12-month data and the program’s future with Ocular Therapeutix’s CEO
- blonca9
- Jun 12, 2023
- 1 min read
Updated: Jun 15, 2023
Ocular Therapeutix CEO Antony Mattessich describes the 12-month data his company has reported for its extended release TKI for wet AMD.